摘要
背景:骨肉瘤(OS)是一种以年轻人为主的肿瘤性疾病,它通常发生在骨生长的区域,肿瘤细胞在晚期呼吸衰竭时转移到肺部。硒。这种疾病没有真正的治疗方法,常规药物会产生副作用,从而降低患者的生活质量。需要新的、更安全的药物,一种途径是使用纳豆。能够阻碍肿瘤生长的铝化合物。 目的:对磷虾油和鱼油这两种生物实体进行评价。在长达72h的时间过程中,将人OS细胞暴露于磷虾油、鱼油、EPA和DHA中。 结果:磷虾油在24、48和72h分别抑制了23、50和64%的细胞增殖,而鱼油在24、48和72小时内无显著变化。 泰雷西汀Gly、EPA和DHA促进了该肿瘤细胞的增殖和迁移。磷虾油对OS的抑制作用与临床常用药物阿霉素0.5和1μ相似。 结论:磷虾油可与标准的临床应用相结合,控制原发性肿瘤的生长,更重要的是控制肿瘤的转移。
关键词: 癌症,DHA,EPA,鱼油,磷虾油,骨肉瘤。
图形摘要
Current Drug Targets
Title:The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration
Volume: 19 Issue: 5
关键词: 癌症,DHA,EPA,鱼油,磷虾油,骨肉瘤。
摘要: Background: Osteosarcoma (OS) is a neoplastic condition afflicting mostly the young, as the lesion usually occurs in areas of bone growth with tumour cells metastasising to the lungs in advanced disease. There is no real cure for the disease, with conventional drugs causing side-effects that decrease the quality of life of sufferers. Newer and safer drugs are needed, and one avenue is to use natural compounds that can stunt the growth of the tumour.
Objective: In this study, two such biological entities were evaluated: krill oil and fish oil. Human OS cells were exposed to krill oil, fish oil, EPA and DHA in time-course assays lasting up to 72h.
Results: Krill oil inhibited 23, 50 and 64% of cell proliferation at 24, 48 and 72h respectively, while fish oil resulted in no significant changes although an increase was observed at 24h. Interestingly EPA and DHA promoted OS cell proliferation and migration in this neoplasia. The inhibitory effect of krill oil was comparable to 0.5 and 1µM doxorubicin, a commonly used clinical drug for OS treatment.
Conclusion: These results indicate that krill oil may be used in combination with standard clinical practices to control primary tumour growth, and more importantly, metastasis.
Export Options
About this article
Cite this article as:
The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration, Current Drug Targets 2018; 19 (5) . https://dx.doi.org/10.2174/1389450116666150107152206
DOI https://dx.doi.org/10.2174/1389450116666150107152206 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Karyotypic Complexity and Chromosomal Instability of Cancer Cells
Current Drug Targets Role of Caspases, Bax and Bcl-2 in Chrysin-Induced Apoptosis in the A549 Human Lung Adenocarcinoma Epithelial Cells
Anti-Cancer Agents in Medicinal Chemistry Anti-cancer and Anti-angiogenic Properties of Various Natural Pentacyclic Tri-terpenoids and Some of their Chemical Derivatives
Current Organic Chemistry Vitamin D - Pivotal Nutraceutical in the Regulation of Cancer Metastasis and Angiogenesis
Current Medicinal Chemistry Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity
Current Medicinal Chemistry From Peptides to Small Molecules: An Intriguing but Intricated Way to New Drugs
Current Medicinal Chemistry Nanomedicine to Overcome Cancer Multidrug Resistance
Current Drug Metabolism Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells
Anti-Cancer Agents in Medicinal Chemistry Molecular Mechanisms Underlying Psychological Stress and Cancer
Current Pharmaceutical Design Overview of Base Excision Repair Biochemistry
Current Molecular Pharmacology Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Current Drug Targets Pathobiology and Therapeutic Implications of Tumor Acidosis
Current Medicinal Chemistry Polymeric Nanocarriers for Drug Delivery in Osteosarcoma Treatment
Current Pharmaceutical Design Alpha-1-Adrenergic Receptor Blockade Modifies Insulin-Regulated Aminopeptidase (IRAP) Activity in Rat Prostate and Modulates Oxytocin Functions
Drug Metabolism Letters Cell Penetrating Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology Stimuli Responsive Nanoparticles for Controlled Anti-cancer Drug Release
Current Medicinal Chemistry Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia
Current Drug Targets Anticancer Chemodiversity of Ranunculaceae Medicinal Plants: Molecular Mechanisms and Functions
Current Genomics Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis
Current Pharmaceutical Design ADAM28 as a Target for Human Cancers
Current Pharmaceutical Design